Clearstead Trust’s Dentsply Sirona XRAY Stock Holding History

Clearstead Trust’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-73	Closed	-$1.16K	–	1573
2025 Q2	$1.16K	Buy	+73	New	+$1.09K	﹤0.01%	1110

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clearstead Trust's XRAY Position: Q3 2025 in Review

Clearstead Trust sold out of Dentsply Sirona (XRAY) in Q3 2025, closing a stake of 73 shares — an estimated $1.16K sold.

Clearstead Trust first reported a position in XRAY in Q2 2025 and held it in 1 quarter. The position peaked at $1.16K in Q2 2025. 411 funds tracked by Wall St. Rank hold XRAY as of Q3 2025.

Clearstead Trust reported no remaining Dentsply Sirona position as of Q3 2025 after selling out during the quarter.
Clearstead Trust sold 73 Dentsply Sirona shares in Q3 2025, an estimated $1.16K.
Clearstead Trust first reported a position in Dentsply Sirona in Q2 2025 and held it in 1 quarter.
Clearstead Trust's Dentsply Sirona position peaked at $1.16K in Q2 2025.
411 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2025.

Based on Clearstead Trust's 13F filing for Q3 2025, filed 10 Nov 2025.